{"id":640837,"date":"2023-03-01T21:22:01","date_gmt":"2023-03-01T21:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=640837"},"modified":"2023-03-01T21:22:01","modified_gmt":"2023-03-01T21:22:01","slug":"gastroesophageal-reflux-disease-gerd-market-to-grow-rapidly-during-the-forecast-period-20222032-delveinsight-key-companies-addpharma-renexxion-hk-innon-phathom-pharma-jiangsu-sindora","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/gastroesophageal-reflux-disease-gerd-market-to-grow-rapidly-during-the-forecast-period-20222032-delveinsight-key-companies-addpharma-renexxion-hk-innon-phathom-pharma-jiangsu-sindora_640837.html","title":{"rendered":"Gastroesophageal Reflux Disease (GERD) Market to Grow Rapidly During the Forecast Period (2022-2032) – DelveInsight | Key Companies – Addpharma, Renexxion, HK inno.N, Phathom Pharma, Jiangsu Sindora"},"content":{"rendered":"
\n
\"Gastroesophageal<\/a><\/div>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Gastroesophageal Reflux Disease (GERD) Market is anticipated to grow immensely in the coming years owing to the rise in the number of prevalent cases of GERD patients, the rise in the healthcare spending across the world and the launch of the emerging therapies.<\/div>\n

Key players, such as Phathom Pharmaceutical, Takeda, Sinorda Biomedicine,<\/strong> and others, are actively involved in developing drugs for Gastroesophageal reflux disease (GERD).<\/p>\n

DelveInsight’s “Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Gastroesophageal Reflux Disease market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).<\/p>\n

The Gastroesophageal Reflux Disease market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Gastroesophageal<\/p>\n

Gastroesophageal Reflux Disease (GERD): An Overview<\/strong><\/p>\n

Gastroesophageal reflux disease (GERD) is a digestive disorder that occurs when acidic stomach juices, food, and fluids back up from the stomach into the esophagus. GERD is the regular, persistent, and long-term occurrence of GER.<\/p>\n

GERD is caused by multiple different mechanisms that can be intrinsic, structural, or both, leading to the disruption of the esophagogastric junction barrier resulting in exposure of the esophagus to acidic gastric contents. The typical clinical presentation of GERD is heartburn and regurgitation. However, GERD can also present with other symptoms, including dysphagia, odynophagia, belching, epigastric pain, and nausea.<\/p>\n

Risk factors for GERD include older age, excessive body mass index (BMI), smoking, anxiety\/depression, and less physical activity at work. Eating habits may also contribute to GERD, including the acidity of food and the size and timing of meals, particularly concerning sleep.<\/p>\n

Gastroesophageal Reflux Disease (GERD) Market Key Facts<\/strong><\/p>\n